Glycated hemoglobin independently predicts stroke recurrence within one year after acute first-ever non-cardioembolic strokes onset in a chinese cohort study

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Wu, Shuolin ^a   Shi, Yuzhi ^a   Wang, Chunxue ^a   Jia, Qian ^a   Zhang, Ning ^a   Zhao, Xingquan ^a   Liu, Gaifen ^a   Wang, Yilong ^a   Liu, Liping ^a   Wang, Yongjun ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CHINESE; COHORT ANALYSIS; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MALE; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR;

AGED; CHINA; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; ODDS RATIO; PROGNOSIS; PROSPECTIVE STUDIES; RECURRENCE; RISK FACTORS; STROKE; TIME FACTORS;

EID: 84893165920     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080690     Document Type: Article

References (46)

1. Liu L, Wang D, Wong KS, Wang Y (2011) Stroke and Stroke Care in China: Huge Burden, Significant Workload, and a National Priority. Stroke 42: 3651-3654. doi:10.1161/STROKEAHA.111.635755. PubMed: 22052510.
2. Wang Y, Xu J, Zhao X, Wang D, Wang C et al. (2013) Association of hypertension with stroke recurrence depends on ischemic stroke subtype. Stroke 44: 1232-1237. doi:10.1161/STROKEAHA.111.000302. PubMed: 23444308.
3. Allen NB, Holford TR, Bracken MB, Goldstein LB, Howard G et al. (2010) Geographic variation in one-year recurrent ischemic stroke rates for elderly Medicare beneficiaries in the USA. Neuroepidemiology 34: 123-129. doi:10.1159/000274804. PubMed: 20068358.
4. Coutts SB, Hill MD, Eliasziw M, Fischer K, Demchuk AM et al. (2011) Final 2 year results of the vascular imaging of acute stroke for identifying predictors of clinical outcome and recurrent ischemic eveNts (VISION) study. BMC Cardiovasc Disord 11: 18. doi:10.1186/1471-2261-11-18. PubMed: 21513559.
5. Weimar C, Diener HC, Alberts MJ, Steg PG, Bhatt DL et al. (2009) The Essen stroke risk score predicts recurrent cardiovascular events: a validation within the REduction of Atherothrombosis for Continued Health (REACH) registry. Stroke 40: 350-354. doi:10.1161/STROKEAHA.108.521419. PubMed: 19023098.
6. Ford ES, Zhao G, Li C (2010) Pre-diabetes and the risk for cardiovascular disease: a systematic review of the evidence. J Am Coll Cardiol 55: 1310-1317. doi:10.1016/j.jacc.2009.10.060. PubMed: 20338491.
7. Lee M, Saver JL, Hong KS, Song S, Chang KH et al. (2012) Effect of pre-diabetes on future risk of stroke: meta-analysis. BMJ 344: e3564. doi:10.1136/bmj.e3564. PubMed: 22677795.
8. Donahue RP, Dorn JM, Stranges S, Swanson M, Hovey K et al. (2011) Impaired fasting glucose and recurrent cardiovascular disease among survivors of a first acute myocardial infarction: evidence of a sex difference? The Western New York experience. Nutr Metab Cardiovasc Dis 21: 504-511. doi:10.1016/j. numecd.2009.11.012. PubMed: 20227262.
9. American Diabetes Association (2011) Standards of medical care in diabetes-2011. Diabetes Care 34 (suppl 1): S11-S61. doi:10.2337/dc11-S011. PubMed: 21193625.
10. American Diabetes Association (2012) Diagnosis and classification of diabetes mellitus. Diabetes Care 35 (Suppl 1): S64-S71. doi:10.2337/dc12-s064. PubMed: 22187472.
11. Chmielewska B, Hasiec T, Belniak Legić E, Stelmasiak Z (1999) Usefulness of current and retrospective markers of glycemia for early prognostication of ischemic stroke in diabetics and non-diabetics. Ann Univ Mariae Curie Sklodowska Med 54: 261-267. PubMed: 11205774.
12. Stettler C, Allemann S, Jüni P, Cull CA, Holman RR et al. (2006) Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. Am Heart J 152: 27-38. doi:10.1016/j.ahj. 2005.09.015. PubMed: 16824829. (Pubitemid 43974725)
13. Alter M, Lai SM, Friday G, Singh V, Kumar VM et al. (1997) Stroke recurrence in diabetics. Does control of blood glucose reduce risk? Stroke 28: 1153-1157. doi:10.1161/01.STR.28.6.1153. PubMed: 9183342. (Pubitemid 27248887)
14. Jia Q, Zheng H, Zhao X, Wang C, Liu G et al. (2012) Abnormal glucose regulation in patients with acute stroke across China: prevalence and baseline patient characteristics. Stroke 43: 650-657. doi:10.1161/STROKEAHA.111.633784. PubMed: 22267822.
15. Bamford J, Sandercock P, Dennis M, Burn J, Warlow C (1991) Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337: 1521-1526. doi:10.1016/0140-6736(91)93206-O. PubMed: 1675378.
16. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB et al. (1993) Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST Trial of Org 10172 in Acute Stroke Treatment. Stroke 24: 35-41. (Pubitemid 23014379)
17. Levy JC, Matthews DR, Hermans MP (1998) Correct homeostasis model assessment (HOMA) evaluation uses the computer program (Letter) Diabetes Care 2Yanvar: 2191-2192 doi:10.2337/diacare.21.12.2191. PubMed: 9839117.
18. National Glycohemoglobin Standardization Program (NGSP) (2013) List of NGSP certified methods. The NGSP web site [online]. Available: http://www.ngsp.org/docs/methods.pdf. Accessed 1 May 2013.
19. Schwartz KL, Monsur JC, Bartoces MG, West PA, Neale AV (2005) Correlation of same-visit HbA1c test with laboratory-based measurements: a MetroNet study. BMC Fam Pract 6: 28. doi: 10.1186/1471-2296-6-28. PubMed: 16014170.
20. the WHO. task force on stroke and other cerebrovascular disorders (1989); Stroke-1989. Recommendations on stroke prevention, diagnosis, and therapy. Stroke 20 (1407-1431).
21. Arima H, Chalmers J (2011) PROGRESS: Prevention of Recurrent Stroke. J Clin Hypertens (Greenwich) 13: 693-702. doi:10.1111/j.1751-7176.2011.00530.x. PubMed: 21896153.
22. Kono Y, Yamada S, Kamisaka K, Araki A, Fujioka Y et al. (2011) Recurrence risk after noncardioembolic mild ischemic stroke in a Japanese population. Cerebrovasc Dis 31: 365-372. doi:10.1159/000323233. PubMed: 21252505.
23. An YC, Chen YX, Wang YX, Zhao XJ, Wang Y et al. (2011) Risk factors on the recurrence of ischemic stroke and the establishment of a Cox's regression model. Zhonghua Liu Xing Bing Xue Za Zhi 32: 816-820. PubMed: 22093475.
24. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, Fallon O. WM, et al. (2000) Ischem ic stroke subtypes: a population-based study of functional outcome, survival, and recurrence. Stroke 31: 1062-1068 (Pubitemid 30253526)
25. Ichikawa H, Shimizu Y, Kuriki A, Murakami H, Mukai M et al. (2012) The brainstem is at high risk for recurrent noncardioembolic cerebral infarction in association with diabetes mellitus: a hospital-based study. Eur Neurol 67: 26-32. doi:10.1159/000333284. PubMed: 22156737.
26. Gast KB, Tjeerdema N, Stijnen T, Smit JW, Dekkers OM (2012) Insulin resistance and risk of incident cardiovascular events in adults without diabetes: meta-analysis. PLOS ONE 7: e52036. doi:10.1371/journal.pone.0052036. PubMed: 23300589.
27. Chiquete E, Ruiz-Sandoval JL, Murillo-Bonilla LM, Arauz A, Orozco-Valera DR et al. (2013) Serum uric acid and outcome after acute ischemic stroke: PREMIER study. Cerebrovasc Dis 35: 168-174. doi:10.1159/000346603. PubMed: 23446426.
28. Toole JF, Malinow MR, Chambless LE, Spence JD, Pettigrew LC et al. (2004) Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 291: 565-575. doi:10.1001/jama.291.5.565. PubMed: 14762035. (Pubitemid 38500310)
29. Kuwashiro T, Sugimori H, Ago T, Kamouchi M, Kitazono T et al. (2012) Risk factors predisposing to stroke recurrence within one year of noncardioembolic stroke onset: the Fukuoka Stroke Registry. Cerebrovasc Dis 33: 141-149. doi:10.1159/000334190. PubMed: 22179660.
30. Kirshner HS (2009) Differentiating ischemic stroke subtypes: risk factors and secondary prevention. J Neurol Sci 279: 1-8. doi:10.1016/j.jns.2008.12.012. PubMed: 19185319.
31. Sacks DB (2011) A1C versus glucose testing: a comparison. Diabetes Care 34: 518-523. doi:10.2337/dc10-1546. PubMed: 21270207.
32. Study ACCORD Group, Buse JB, Bigger JT, Byington RP, Cooper LS et al. (2007) Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods. Am J Cardiol 99: 21i-33i. doi:10.1016/j.amjcard.2007.03.003. PubMed: 17599422.
33. Patel A, ADVANCE Collaborative Group, MacMahon S, Chalmers J, Neal B et al. (2007) Effects of a fixed combination of perindopri and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomized controlled trial. Lancet 370: 829-840. doi:10.1016/S0140-6736(07)61303-8. PubMed: 17765963. (Pubitemid 47362321)
34. Duckworth W, Abraira C, Moritz T, Reda D, Emanuele N et al. (2009) Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 360: 129-139. doi:10.1056/NEJMoa0808431. PubMed: 19092145.
35. Ismail-Beigi F, Moghissi ES (2008) Glycemia management and cardiovascular risk in type 2 diabetes: an evolving perspective. Endocr Pract 14: 639-643. doi:10.4158/EP.14.5.639. PubMed: 18753110.
36. Skyler JS, Bergenstal R, Bonow RO, Buse J, Deedwania P et al. (2009) Intensive glycemic control and the prevention of cardiovascular events: implications of the ACCORD, ADVANCE, and VA diabetes trials: a position statement of the American Diabetes Association and a scientific statement of the American College of Cardiology Foundation and the American Heart Association. Diabetes Care 32: 187-192. doi:10.2337/dc08-9026. PubMed: 19092168.
37. Selvin E, Steffes MW, Zhu H, Matsushita K, Wagenknecht L et al. (2010) Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. N Engl J Med 362: 800-811. doi:10.1056/NEJMoa0908359. PubMed: 20200384.
38. Zoungas S, Chalmers J, Ninomiya T, Li Q, Cooper ME et al. (2012) Association of HbA1c levels with vascular complications and death in patients with type 2 diabetes: evidence of glycaemic thresholds. Diabetologia 55: 636-643. doi:10.1007/s00125-011-2404-1. PubMed: 22186981.
39. Terry T, Raravikar K, Chokrungvaranon N, Reaven PD (2012) Does Aggressive Glycemic Control Benefit Macrovascular and Microvascular Disease in Type 2 Diabetes?: Insights from ACCORD, ADVANCE, and VADT. Curr Cardiol Rep 14: 79-88. doi:10.1007/s11886-011-0238-6. PubMed: 22160862.
40. Japan Diabetes Society (2007) Treatment objectives and control indicators. In: Japan Diabetes Society, editor. Treatment guide for diabetes; (2007). Tokyo Bunkodo: 1-84.
41. Kamouchi M, Matsuki T, Hata J, Kuwashiro T, Ago T et al. (2011) Prestroke glyemic control is associated with the functional outcome in acute ischemic stroke: The Fukuoka Stroke Registry. Stroke 42: 2788-2794. doi:10.1161/ STROKEAHA.111.617415. PubMed: 21817134.
42. Oh HG, Rhee EJ, Kim TW, Lee KB, Park JH et al. (2011) Higher Glycated Hemoglobin Level Is Associated with Increased Risk for Ischemic Stroke in Non-Diabetic Korean Male Adults. Diabetes Metab, 35: J 35: 551-557 PubMed: 22111048.
43. American Diabetes Association (2012) Executive summary: Standards of medical care in diabetes - 2012. Diabetes Care 35 Suppl 1: S4-S10. doi:10.2337/dc11-1967. PubMed: 22187471.
44. Poppe AY, Majumdar SR, Jeerakathil T, Ghali W, Buchan AM et al. (2009) Canadian Alteplase for Stroke Effectiveness Study Investigators: Admission hyperglycemia predicts a worse outcome in stroke patients treated with intravenous thrombolysis. Diabetes Care 32: 617-622. doi:10.2337/dc08-1754. PubMed: 19131465.
45. Fuentes B, Ortega-Casarrubios MA, Sanjosé B, Castillo J, Leira R et al. (2010) Stroke Project of the Cerebrovascular Diseases Study Group Spanish Society of Neurology: Persistent hyperglycemia > 155 mg/dL in acute ischemic stroke patients: how well are we correcting it? Implications for outcome. Stroke 41: 2362-2365. doi:10.1161/STROKEAHA.110.591529. PubMed: 20724713.
46. Adams RJ, Appleton SL, Hill CL, Wilson DH, Taylor AW et al. (2009) Independent association of HbA(1c) and incident cardiovascular disease in people without diabetes. Obesity (Silver Spring) 17: 559-563. doi:10.1038/oby.2008. 592. PubMed: 19131940.